OvaScience to Launch New Potential Fertility Treatment OvaPrime in 2015

OvaScienceSM, OVAS today provided an update on its product pipeline and commercial plans, which are based on its egg precursor cell (EggPCSM) technology platform. OvaScience expects to commercialize AUGMENTSM in international in vitro fertilization (IVF) clinics in 2014 and to launch its newest potential fertility treatment, OvaPrimeSM, in 2015. See full press release
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsGuidanceManagementGlobal
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!